Posters 26 - 29 May, 2019 03. Lipids - 03.10 Novel aspects of dyslipidemia treatment| Volume 287, e201, August 2019

D-Allulose Alters Serum Cholesterol Levels Partly Via Reducing Serum Pcsk9 Levels In Hamsters.

      Background and Aims: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are reported to degrade LDL receptors and thereby prevent hypercholesterolemia. Thus, regulation of PCSK9 levels might prevent the onset of dislipidemia. However, little is known if food ingredients can regulate circulating PCSK9 levels. D-Allulose, an epimer of D-fructose, is one of rare sugars and is a non-caloric sweetener having several health benefits, including suppression of increased serum glucose levels and fat accumulation. However, the effects of D-allulose on cholesterol metabolism are unclear. Here, we examined the effects of D-allulose on PCSK9 levels and cholesterol metabolism in Golden Syrian hamsters.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect